A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway
|
|||||
       
 |
 One comment - (Comments are closed)  Finance, New products  biomedical, chemistry, computer science, engineering, entrepreneurs, equity, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences, physics, preclinical, semiconductors, university, venture capital 
National Institutes of Health is funding research on an experimental gene therapy delivered with nanoparticles to treat opioid use disorder. . . . → Read More: NIH Funding Nanoparticle Gene Therapy for Opioid Disorder Comments are closed Finance, Joint ventures/collaborations, New products biomedical, biotechnology, engineering, genomics, grant, life sciences, nanotechnology, NIH, pharmaceuticals, preclinical, university 
Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions. . . . → Read More: New Industry, Academic Studies Arrive at Space Station Comments are closed Joint ventures/collaborations, New products agriculture, biomedical, biotechnology, cancer, engineering, life sciences, manufacturing, materials science, mathematics, nanotechnology, NASA, physical sciences, physics, space, university 
Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells. . . . → Read More: Exosomes Shown to Block Broad Covid-19 Variant Range Comments are closed New products biotechnology, Covid-19, entrepreneurs, life sciences, nanotechnology, patent, pharmaceuticals, preclinical, university 
A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion. . . . → Read More: Biotech Partners on Gene Editing Tech in $1.35B Deal Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, genomics, licensing, life sciences, nanotechnology, pharmaceuticals 
A clinical trial testing a vaccine to protect against Covid-19 disease, given as a nasal spray, is scheduled to begin later this year in the Netherlands. . . . → Read More: Trial Set for Covid-19 Nasal Spray Vaccine Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, clinical trials, Covid-19, Europe, nanotechnology, pharmaceuticals, preclinical, university 
A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, Covid-19, licensing, life sciences, manufacturing, nanotechnology, pharmaceuticals, physical sciences
A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round. . . . → Read More: Gene Therapy Delivery Company Gains $26M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray Comments are closed Intellectual property, New products biomedical, chemistry, engineering, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, U.K. 
A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases. . . . → Read More: Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, engineering, Europe, genomics, licensing, life sciences, nanotechnology, pharmaceuticals, university |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
